Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chart: FDA Revitalization Act: Device-Related Provisions

This article was originally published in The Gray Sheet

You may also be interested in...



Markup Of Pediatric Device Bill Slated For June In House

The House Energy and Commerce Committee expects to mark up a pediatric medical device bill in June. The goal is to have the Pediatric Medical Device Safety and Improvement Act (HR 1494) ready for a floor debate and vote in July, according to committee staffers

Industry Dissatisfied With Senate-Approved Pediatric Device Provisions

Device industry lobbyists are seeking changes to provisions in the Senate user fee reauthorization bill relating to medical devices for children

Senate Passes User Fee Reauthorization With FDA/Industry Proposals Intact

Legislation reauthorizing the medical device user fee program passed the Senate May 9. Action is now needed in the House to prevent the program from expiring on September 30

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024782

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel